Adenocarcinomas of esophagogastric junction: Multi-detector row CT to evaluate early response to neoadjuvant chemotherapy

Radiology

Volumn 239, Issue 2, 2006, Pages 472-480

  Beer, Ambras J ^a   Wieder, Hinrich A ^a   Lordick, Florian ^a   Ott, Katja ^a   Fischer, Michael ^a   Becker, Karen ^a   Stollfuss, Jens ^a   Rummeny, Ernst J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; IMERON 300; IOMEPROL; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; MALE; MEASUREMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBSERVER VARIATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646137149     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2391050043     Document Type: Article

References (20)

1. Geh JI, Crellin AM, Glynne-Jones H. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
2. Ketsen D. Multimodal therapy for adenocarcinoma of the esophagus. Gastroenterol Clin North Am 1997;26: 635-645.
3. Lordick F, Stein HJ, Peschel C, Siewert JR. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 2004;91:540-551.
4. Chang AY. Treatment of esophageal cancer [letter]. N Engl J Med 1999;340:1686-1687.
5. Schuhmacher CP, Fink U, Becker K, et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum: closing results after 5 years of follow-up. Cancer 2001;91:918-927.
6. Stein HJ, Fink U, Siewert JR. Who benefits from combined modality treatment of esophageal carcinoma? Dis Esophagus 1994;7:156-161.
7. Fink U, Stein HJ. Treatment of esophageal cancer [letter]. N Engl J Med 1999;340:1685.
8. Weher WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-3065.
9. Wieder HA, Bruecher BL, Zimmermann F, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal sqnamous cell carcinoma and response to treatment. J Clin Oncol 2004;22:900-908.
10. Pfau PR, Kochmann ML. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Gastrointest Endosc 2000;52:583-586.
11. Brown WA, Thomas J, Gotley D, et al. Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy. Br J Surg 2004;91:199-204.
12. Jones DR, Parker LA, Detterbeck FC, Egan TM. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 1999;85:1026-1032.
13. Becker K, Mueller J, Schuhmacher C, et al. Histomorphology and grading of regression in gastric cancer treated with neoadjuvant chemotherapy. Cancer 2003;98:1521-1530.
14. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994;73:2680-2686.
15. Metz CE. Some practical issues of experimental design and data analysis in radiological ROC studies. Invest Radiol 1989;24:234-245.
16. Walker SJ, Allen SM, Steel A, Cullen MH, Matthews HR. Assessment of the response to chemotherapy in oesophageal cancer. Eur J Cardiothorac Surg 1991;5: 519-522.
17. Ng CS, Husband JE, MacVicar AD, Ross P, Cunningham DC. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol 1998;53:422-427.
18. Griffith JF, Chan AC, Chow LT, et al. Assessing chemotherapy response of squamous cell oesophageal carcinoma with spiral CT. Br J Radiol 1999;72:678-684.
19. Liang EY, Chan A, Chung SC, Metreweli C. Oesophageal tumor volume measurement using spiral CT. Br J Radiol 1996;69:344-347.
20. Ott K, Fink U, Becker K, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 2003;21:4604-4610.